Logo

Nanosphere Raises $35.3M in Public Offering

Oct 22, 2009

NEW YORK (GenomeWeb News) – Nanosphere has closed a public offering of its common stock, raising approximately $35.3 million.

The Northbrook, Ill.-based molecular diagnostics firm sold 5,405,000 shares of common stock at a price of $7 per share. The total number of shares sold includes 705,000 shares that comprised the over-allotment option.

Nanosphere said that it will use the proceeds for general corporate purposes and working capital.

Filed under

Diagnostics
Business News
stock offering
Luminex
Breaking News
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.